Pleased to have presented our work on predicting hip fractures in people with type 2 diabetes at @iofbonehealth World Congress of Osteoporosis 2026 #OsteoCongress in Prague 🇨🇿
Repeating RFA within 6 months for large solid thyroid nodules (>=20ml) led to continued shrinkage beyond 12months (18-month VRR 82%). Varying the time to retreat in 6months had little influence.
Providing more insights into this MIS treatment. @hkumed@HKUSurgery@BrianHLang1
Our paper comparing QOL after RFA vs RAI vs surgery for Graves disease discussed -
https://t.co/uXCTSM79yS
We are not just treating the labs. Quality of life matters.@WorldJSurg
Laryngeal ultrasound-guided adhesive transcutaneous electrodes versus ... https://t.co/7Awc5wQV11 great investigation by @FungMatrix@BrianHLang1 in @SurgJournal
Our study: Single RFA vs MWA for benign thyroid nodules, matched for nodule volumes. n=208, 12-month FU.
RFA=MWA for nodules<20mL
MWA may achieve greater VRR for nodules >=20mL.
https://t.co/LBQix9894n
Prospective trials on the way.@EurRadiology @hkumed@HKUSurgery@BrianHLang1
Our study: Using AI to bridge the expertise gap in surgeon-performed thyroid #ultrasound. We are in the exciting era of AI enhanced medical care and education. @AmJSurgery@BrianHLang1@HKUSurgery@hkumed
https://t.co/Bo13U8Ljvf
Among patients with primary hyperparathyroidism, parathyroidectomy was associated with a lower risk of incident #diabetes. https://t.co/tQaoHuxUZ6 @DavidLui_HKU@FungMatrix
Our 7-y single-centre study of adrenal incidentaloma supports benefits of lap adrenalectomy for Mx of mild autonomous cortisol secretion, published in @TheAACE Endocr Prac.
Great collab exp with EndoSurg
@FungMatrix@BrianHLang1@hkumed
Article link:
https://t.co/jHpyZf1abL
Proud collaboration with @HKU_D24H leveraging ensemble AI approach with lightweight LLMs for thyroid cancer staging and risk stratification. Excited for the era of AI-enhanced clinical medicine! @npjDigitalMed@HKUSurgery@CarlosWongHKU@jtkwu@BrianHLang1 https://t.co/Qj4KxShW2A
The role of using molecular test to reduce unnecessary surgeries for cytologically indeterminate thyroid nodules in an Asian population studied with data from @HKUSurgery
A potentially cost-saving approach if test cost could be lowered.https://t.co/0jiDahy2SU
@BrianHLang1
Glad to share the experience from our RFA series:
For large benign nodules (>=20ml), early re-ablation led to better and continued nodule shrinkage when compared to single ablation.
@HKUSurgery@BrianHLang1@TheAAES
https://t.co/OLaFGYsCl6
Our retrospective study of patients in #obesity clinic 🇭🇰 showed effectiveness of naltrexone-bupropion (Contrave) as an oral anti-obesity 💊, achieving up to 9% weight loss at 6mo extending to 12mo, published in Endocrine.
@hkumed
Full text here 👉🏼 https://t.co/uj3ALXh6Vh
[Lecture by Professor Cord Sturgeon]
HKU Surgery was honoured to have Professor Cord Sturgeon, Professor of Surgery, Vice-Chair of Surgery and Section Chief of Endocrine Surgery at Northwestern University, Feinberg School of Medicine in Chicago, U.S.A. and the past president of @TheAAES, to speak on the topic “Usefulness of Molecular Testing in Indeterminate Thyroid Nodules” on 29 August 2024.
As an eminent scholar and surgeon, Professor Sturgeon has been invited give talks all around the world. We would like to thank him for coming to Hong Kong again to share his wealth of insights with our staff members and participants! ☺️
#HKUSurgery #hkumed #endocrinesurgery
Optimizing pain control for thyroid ablation with cervical plexus block (CPB) - our experience
n=100
CPB arm: better pain control (NRS 1 vs 4);
0 pain: 44% with CPB vs 14% without
No adverse events, ambulatory procedure
@HKUSurgery@BrianHLang1
https://t.co/lqbcmiatNo